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Abstract
A key hallmark of the vertebrate adaptive immune system is the generation of antigen-specific antibodies from B cells. Fish
are the most primitive gnathostomes (jawed vertebrates) possessing an adaptive immune system. Vaccination of rainbow
trout against enteric redmouth disease (ERM) by immersion in Yersinia ruckeri bacterin confers a high degree of protection
to the fish. The immune mechanisms responsible for protection may comprise both cellular and humoral elements but the
role of specific immunoglobulins in this system has been questioned and not previously described. The present study
demonstrates significant increase in plasma antibody titers following immersion vaccination and significantly reduced
mortality during Y. ruckeri challenge. Rainbow trout were immersion-vaccinated, using either a commercial ERM vaccine
(AquaVacTM ERM vet) or an experimental Y. ruckeri bacterin. Half of the trout vaccinated with AquaVacTM ERM vet received
an oral booster (AquaVacTM ERM Oral vet). Sub-groups of the fish from each group were subsequently exposed to 1x109
CFU Y. ruckeri/ml either eight or twenty-six weeks post vaccination (wpv). All vaccinated groups showed 0% mortality when
challenged, which was highly significant compared to the non-vaccinated controls (40 and 28% mortality eight and twenty-
six weeks post vaccination (wpv), respectively) (P,0.0001). Plasma samples from all groups of vaccinated fish were taken 0,
4, 8, 12, 16 and 26 wpv. and Y. ruckeri specific IgM antibody levels were measured with ELISA. A significant increase in titers
was recorded in vaccinated fish, which also showed a reduced bacteremia during challenge. In vitro plasma studies showed
a significantly increased bactericidal effect of fresh plasma from vaccinated fish indicating that plasma proteins may play a
role in protection of vaccinated rainbow trout.
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Introduction
Yersinia ruckeri is the aetiological agent of enteric red mouth
(ERM) disease or yersiniosis, affecting salmonids in general and
rainbow trout in particular [1,2]. Although generally well
controlled by means of vaccination and antibiotic treatment, this
disease is still causing outbreaks in all trout-producing countries
worldwide [3]. In some cases the losses due to this disease can be
as high as 30–70% of the stock [4]. Protective immunity in
rainbow trout against ERM induced by immersion vaccination
using formalin killed Y. ruckeri has been known since 1976. The
method meets the requirements of the trout farming industry and
their call for easily handled vaccination techniques, high through-
put of animals in a short time, a low stress-induction, a good
protection and high safety [5,6]. Y. ruckeri bacterin can be
administrated by intraperitoneal (i.p.) injection, immersion and
oral administration [7] and the obtained protective immunity is
superior with i.p. injection followed by immersion, and oral
administration [7]. The explanation for this observation might be
that the protective effect of the bacterin seem to be dependent on
the amount of bacterin uptake in the rainbow trout [8]. In
salmonids gill epithelial cells have been shown to be an important
site for bacterin uptake following immersion vaccination [9,10]. It
has been demonstrated that the duration of protective immunity
depends on the bacterin concentration, length of immersion time,
antigen uptake and the size and species of fish [11]. However the
immunological mechanism behind the protective effect of the
ERM immersion vaccination is still not fully described [6]. It has
been reported that antibodies in rainbow trout only in few cases
are associated with protection following immersion vaccination
[12] and protection induced by i.p. injection of Y. ruckeri bacterin
does not seem to be due to agglutinating antibodies [13,14]. A
range of genes encoding immune relevant effector molecules are
known to be activated in the spleen of ERM immersion vaccinated
rainbow trout fry, indicating activation of a systemic immune
response [15]. Since Y. ruckeri is primarily an extracellular
pathogen, and immersion vaccinated rainbow trout are protected
against ERM for a least one year [16] is it likely that specific
antibodies are among the protective mechanism. The purpose of
the present study is to investigate whether there is an association
between production of specific antibodies against Y. ruckeri and the
protection in immersion vaccinated rainbow trout. Further, the
effect of an oral booster vaccination following a primary
immersion vaccination was evaluated.
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Materials and Methods
Fish and rearing conditions
Rainbow trout (Skinderup strain from Jutland, Denmark) were
hatched and reared under pathogen-free conditions (Danish
Centre for Wild Salmon, Randers, Denmark). The pathogen-free
status was achieved by introducing certified disinfected eggs to the
recirculated system. Fish were brought to the experimental fish
keeping facility at the University of Copenhagen when reaching an
average body weight of 2563 g. The pathogen-free status of the
fish was confirmed by standard bacteriological and parasitological
techniques upon their arrival in the laboratory. To confirm that
fish were sero-negative for Y. ruckeri blood samples for specific
ELISA-tests were taken regularly from the same batch of fish
before experimental start (data not shown).
The 800 fish were kept in four 120 L tanks (Fig. 1) with bio-
filters (Eheim, Germany) and maintained at a 12 h light and 12 h
dark cycle in aerated (100% oxygen saturation) tap water at 13uC.
They were fed a commercial trout feed (BioMar, Denmark) (1%
biomass per day). All procedures were conducted in accordance
with the regulations set forward by the Danish Ministry of Justice
and animal protection committees by Danish Animal Experiments
Inspectorate permit 2006/561-1302 and in compliance with
European Community Directive 86/609. The present study were
approved and controlled by our institutional review board with the
FELASA accreditation No 006/03/28.
Vaccines
Three vaccines were used in the present experiment (Fig. 1).
One was an experimental immersion vaccine consisting of a
bacterin of 56109 formalin killed Y. ruckeri/ml. The strain used was
serotype O1, biotype 1, with confirmed virulence for rainbow
trout [15,17,18,19]. The bacteria were grown in LB-medium
(Oxoid LP0042, Tryptone 10 g, Oxoid LP0021Yeast-extract 5 g,
NaCl 5 g, H2O to 1000 ml, pH 7.4) at 20uC for 36 h and
enumerated as colony forming units (CFU) by the spread plate
method on blood agar (Blood agar base CM55 [Oxoid]
supplemented with 5% bovine blood). Y. ruckeri were killed by
adding 1% formaldehyde to the culture and subsequently
incubating for 2 hours on a plate shaker. The killed bacteria were
washed 3 times with PBS and the effect of formaldehyde killing
was verified by plate spreading onto blood agar.
The second immersion vaccine used was the commercial
AquaVacTM ERM (Intervet/Schering-Plough Animal Health)
containing 56109 CFU/ml formalin killed Y. ruckeri (Hagerman
strain, serotype O1, biotype 1). The third vaccine used was the
oral booster vaccine AquaVacTM ERM Oral vet (Intervet/
Schering-Plough Animal Health) containing 56108 CFU/ml
formalin killed Y. ruckeri (Hagerman strain, serotype O1, biotype
1).
Vaccination
A total of 800 rainbow trout were divided into four groups each
containing 200 fish (Fig. 1). One group of 200 rainbow trout were
immersion vaccinated with the experimental vaccine. Two groups
were immersion-vaccinated with the commercial AquaVacTM
ERM. One of these groups received an oral booster vaccination
with AquaVacTM ERM Oral vet 16 weeks post immersion
vaccination. The oral booster vaccine was coated onto the feed
pellets according to the manufacturer’s recommendations (Inter-
vet/Schering-Plough Animal Health). Each fish received 0.01 ml
oral vaccine in feed pr. day from day 1–5, then normal feed
without vaccine from day 6–10, and finally vaccine coated feed
from day 11–15. All immersion vaccines were diluted 1:10 in
water, and the fish were immersed for 5 minutes. The control
groups were sham-bath vaccinated in pure water.
Blood sampling
Ten fish from each group were sampled 0, 4, 8, 12, 16 and 26
weeks post primary vaccination. Fish were killed by an overdose of
MS222 (100 mg/l) (Sigma-Aldrich, Denmark), and blood was
sampled from vena caudalis using heparinised syringes and
immediately centrifuged at 4000 x g for 5 min (4uC), where-upon
plasma was recovered and stored (220uC).
ELISA for determination of Y. ruckeri specific IgM
antibodies
Enzyme-linked immunosorbent assay (ELISA) was used to
detect the presence of Y. ruckeri O1 specific IgM in plasma. For
coating, each well of the microplates (flat-bottom 96-well plates,
MaxiSorpTM, Nunc) was filled with 100 mL coating buffer (50 mM
carbonate buffer, pH 9.6, C-3041, Sigma) containing 5 mg/mL of
antigen (sonically disrupted Y. ruckeri, same isolate as used for
experimental immersion vaccine and challenge experiments) and
incubated overnight at 4uC. After removal of coating solution, the
Figure 1. Flow chart of the experimental setup. A total of 800
rainbow trout were divided into four groups each containing 200 fish.
One group was immersion vaccinated with the experimental bacterin
vaccine. Two groups were immersion-vaccinated with the commercial
AquaVacTM ERM. One of these groups received an oral booster
vaccination with AquaVacTM ERM Oral vet 16 weeks post vaccination.
All vaccines were diluted 1:10 in water, and the fish were immersed for
5 minutes. The control group was sham-immersion vaccinated in pure
water. A subsample of 25 rainbow trout from each group were given a
challenge with Y. ruckeri 8 and 26 weeks post vaccination to monitor
protection. Ten fish from each group were killed and used for plasma
sampling 4, 8, 12, 16, and 26 weeks post vaccination.
doi:10.1371/journal.pone.0018832.g001
Immunity against Yersinia ruckeri
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unbound antigen was removed by three washes with 400 mL
washing buffer (0.1% Tween-20 in phosphate buffered saline
(PBS; pH 7.2)). Blocking of free binding sites was performed by
1 h incubation with 150 ml blocking buffer (1% bovine serum
albumin (BSA) in washing buffer). After blocking, microplates were
washed three times, aspirated, sealed (micro plate seal, Nunc) and
stored at 220uC until use.
The optimal ratio between specific reaction and background
binding was found as a 50 fold dilution of plasma in pilot
experiments (data not shown). Therefore, 50 fold dilutions of
plasma with assay diluents buffer (PBS with 0.5% Tween 20) were
made in triplicate from each fish, whereupon plasma samples were
added to the wells, sealed and incubated at 4uC overnight.
Microplates were then washed three times and 50 mL of a
mouse anti-salmonid Ig antibody solution (MCA2182, AbD
serotec, 1:400 dilution in assay buffer) was added. After 1 h
incubation at room temperature, the micro plates were washed
three times, and 50 ml were added to each well of a Fab’-HRP
solution (STAR13B, AbD serotech, 1:400 dilution in assay buffer).
Optimal concentrations of the commercial antibodies were
established by chessboard titration experiments (data not shown).
Microplates were then incubated for additional 1 h at room
temperature followed by five washes. Substrate solution was added
(100 ml/well of TMB, Sigma) and after 10 min a stop solution
(100 ml 1N HCl/well) was added, and the absorbance was read at
450 (PowerWave 340, BioTek). The limit of detection for the assay
was set as the concentration corresponding to the signal three
standard deviations (0.002) above the mean for blank wells (0.049)
(sample dilution buffer only).
Wells with all antibodies and substrates except sample material
were included as negative controls for the ELISA and this
background OD value was subtracted from all samples. A positive
reference control serum sample, taken from a rainbow trout which
were ip. vaccinated tree times with Yersinia ruckeri bacterin in
Freunds’s incomplete adjuvant, was run in triplicate at each plate
and used as inter-plate calibrator.
Production of high titer reference sera
The injected vaccine contained an 48 h culture of Y. ruckeri O1
which were inactivated with 0.9% formaldehyde for 2 h at room
temperature, washed with PBS, adjusted to an optical density
corresponding to 26108 cells/mL PBS, and emulsified with an
equal volume of Freund’s incomplete adjuvant (FIA; Sigma, St.
Louis, Mo.). The fish was immunised by intraperitoneal injections
with 0.1 mL of formalin-killed bacterial vaccine suspension
(16107 cells/injection). Immunisations were given three times
with 500 day degree intervals (six weeks).
Challenge experiments
Challenge were conducted using 16109 CFU Y. ruckeri/ml in
water for 1 h (corresponding to a previously determined LD50 for
rainbow trout at this size (data not shown), where after fish were
transferred to clean water in the fish tanks. All immersion
vaccinated and control groups were challenged as described. All
fish that survived the 28 days of challenge were killed by an
overdose of MS222 (100 mg/l).
Isolation of Y. ruckeri in fish head kidney following
challenge
Bacterial samples from the head kidney from all fish that died
following challenge were cultured on blood agar plates. Mortalities
were only considered to be caused by Y. ruckeri if this specific
bacteria species was recovered as pure culture from the head
kidney.
Detection of Y. ruckeri in blood in vivo post-infection
Blood were collected from 5 fish (killed with an overdose of MS-
222, 100 mg/l) from each of the four groups 3, 7 and 14 days post
infection, and the number of CFU/ml Y. ruckeri from each fish
were determined by plate spreading onto blood agar in a 10-fold
dilution series (in triplicate) as previously described [18].
Bactericidal effect of plasma in vitro
In order to investigate whether plasma from immersion
vaccinated rainbow trout contained increased amounts of humoral
factors with ability to kill Y. ruckeri an in vitro test was performed
using plasma from fish sampled at 8 and 26 wpv. A 60 ml plasma
aliquot from each fish (n = 10) was mixed 1:1 with Y. ruckeri
(5,66103 CFU/ml in PBS) in a round-bottom 96-well microtiter
plate. After 1 h. at 20uC a volume of 10 ml of the solution was
plated onto blood agar in triplicate. A plasma sample without
bacteria served as a negative control and as a positive control Y.
ruckeri was incubated in PBS without plasma. Heat inactivated
trout plasma samples were included as well but resulted in
excessively Y. ruckeri overgrown agar plates (data not shown).
Calculations and statistical analysis
Results from the challenge experiments were analyzed using the
Kaplan-Meier test, which were used to analyse for differences in
mortality between groups. Kruskal-Wallis test were used to
compare the amount of bacteria in the blood and the bactericidal
effect of plasma between the different groups. ANOVA with
Tukey post test were used to analyse the ELISA results. All
statistical tests were carried out using GraphPad Prism 4
(GraphPad Software, Inc. San Diego, USA) and a significance
level of 5% was applied in all tests.
Results
Challenge experiments
Subsamples of rainbow trout from all immersion vaccinated
groups of rainbow trout showed 0% mortality following bath
challenge with 16109 CFU/ml Y. ruckeri 8 and 26 wpv. All
immersion vaccinated groups had significantly lower mortality
rates than the sham-vaccinated control group (p,0.0001) (Fig. 2).
The mortality in the sham-vaccinated control group was 40% and
28%, 8 and 26 weeks post sham-vaccination, respectively.
Re-isolation of pathogen
Y. ruckeri was re-isolated from the head kidney of all fish that
died following challenge. Dead fish exhibited external signs
associated with ERM infection including petechial haemorrhages
in the mouth, around the anus and at the basis of the dorsal fins.
Detection of Y. ruckeri specific IgM antibodies in plasma
The Y. ruckeri specific IgM antibody titers were significantly
higher 26 weeks post-vaccination compared to week 4 post-
vaccination. In the group immersion vaccinated with the Y. ruckeri
bacterin the titer 26 weeks post vaccination was significantly
higher than the titer obtained 4, 8 and 12 weeks post-vaccination
(P,0.001, P,0.05 and P,0.05) respectively. Titers in weeks 4
and 8 were significantly higher in the group which was immersion
vaccinated with AquaVacTM ERM compared to the fish which
were immersion vaccinated in bacterin (P,0.05).
Immunity against Yersinia ruckeri
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Detection of Y. ruckeri in blood post challenge
The presence of Y. ruckeri in the blood was detected in infected
sham-vaccinated trout at all sampling points post-infection. Three
days post infection (dpi.) Y. ruckeri was only detected in the blood of
fish from the sham-vaccinated group. 7 dpi. bacteria were also
detected in the AquaVacTM ERM vaccinated-group. The absence of
Y. ruckeri 7 dpi. in the blood of the bacterin vaccinated group is highly
significant relative to the non vaccinated group (p,0.01). The CFU/
ml blood of Y. ruckeri increased in the non-vaccinated control group
between each sampling (p,0.001). The CFU/ml of Y. ruckeri in the
blood of sham-vaccinated fish was significantly higher 14 dpi.com-
pared to both the experimental bacterin and AquaVacTM ERM
immersion vaccinated group (p,0.001 and p,0.05). No significant
difference was detected between the two vaccinated groups (Fig. 4).
Bactericidal effect of plasma
Plasma from both sham-vaccinated and vaccinated trout
contained bactericidal factors (Fig. 5) but it was shown that
plasma obtained from trout immersion vaccinated with Y. ruckeri
bacterin and AquaVacTM ERM killed a significantly higher
amount of Y. ruckeri than plasma from sham-vaccinated control
trout taken 8 weeks post-vaccination (p,0.001 and p,0.05),
respectively. Plasma from fish vaccinated by the experimental
bacterin killed a significantly higher number of Y. ruckeri in vitro
compared to plasma from the AquaVacTM ERM immersion
vaccinated fish (p,0.01). Twenty-six weeks post-vaccination no
difference between groups could be detected with regard to the
bactericidal effect of plasma but still a significantly higher
bactericide effect of plasma was found when compared to PBS
(p,0.05). The oral booster vaccination did not influence the
bactericidal effect of plasma (Fig.5 B).
Discussion
Immersion vaccination of salmonids against ERM has been
conducted successfully for more than 30 years but the protective
mechanisms activated by this type of immunization are still being
debated. The involvement of specific IgM antibodies has never
been clearly established but this may be due to the relatively low
sensitivity of the used methods. The present work has showed that
the IgM antibody titers increase significantly following immersion
vaccination against ERM. Increased levels of specific IgM
antibodies against Y. ruckeri relative to sham-vaccinated control
fish were found at 8 and 12 weeks post-vaccination which
correspond to the time required at 12-13uC to develop protective
immunity against water borne ERM [15].
Further, it was shown that immersion vaccinated trout contained
significantly less Y. ruckeri in the blood compared to sham-vaccinated
trout 3–14 days post a bath challenge with Y. ruckeri, given 8 weeks
post-immersion vaccination (Fig.4). This indicates that the vaccine-
induced protection is, at least partly, associated with a control of
Figure 2. Protective effect of immersion vaccines following bath challenge. A). Percentage survival of Y. ruckeri bath infected rainbow trout
(n = 25 in each group) eight weeks post immersion vaccination and B) twenty-six weeks post immersion vaccination. All immersion vaccinated groups
of rainbow trout showed a survival rate of 100% during bath challenge with 16109 CFU/ml Y. ruckeri 8 and 26 weeks post vaccination, which is
significantly higher survival rate than the sham-vaccinated control group (p,0.0001). The mortality in the sham vaccinated control group was 40%
(A) and 28% (B), 8 and 26 weeks, respectively.
doi:10.1371/journal.pone.0018832.g002
Immunity against Yersinia ruckeri
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bacteria in the blood. One of the protective mechanisms reducing
the amount of Y. ruckeri in the blood of immersion vaccinated
rainbow trout could be an increase of bactericidal factors in plasma.
It was shown that plasma from even sham-vaccinated rainbow trout
contains factors that is able to kill a significant amount of Y. ruckeri (in
vitro), and that the bactericidal effect is further increased in plasma
taken from immersion vaccinated trout 8 weeks post-vaccination.
Plasma from ERM bacterin immersion vaccinated rainbow trout
Figure 3. Detection of Y. ruckeri specific IgM antibodies in plasma post ERM immersion vaccination. The ELISA method was used to
detect Y. ruckeri specific IgM antibodies in plasma. The antibody titer were significantly higher in immersion vaccinated groups compared to the
sham vaccinated group (*P,0.05).
doi:10.1371/journal.pone.0018832.g003
Figure 4. Presence of Y. ruckeri in blood post infection. Amount of Y. ruckeri in blood of bath challenged rainbow trout from each immersion
vaccinated group (eight weeks post-vaccination). Blood samples (n = 5) were taken 3, 7 and 14 days post-infection. The amount of Y. ruckeri in blood
was significantly lower in the groups of immersion vaccinated rainbow trout compared to the sham vaccinated group. Bars represent mean values +
SD values. * Depicts statistical significance between vaccinated groups (*P,0.05; **P,0.01; ***P,0.001).
doi:10.1371/journal.pone.0018832.g004
Immunity against Yersinia ruckeri
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has a higher bactericidal effect than AquaVacTM ERM immersion
vaccinated trout. One reason for this could be that the experimental
bacterin vaccine and Y. ruckeri strain used for the in vitro experiment
is the same isolate.
The vaccine induced increase in bacterial killing is probably not
only due to increased antibody levels, since the bacterin vaccinated
group (showing the highest in vitro killing of Y. ruckeri) showed no
increase of the antibody level 8 weeks post-vaccination (Fig. 3 and
5). Further studies should elucidate if innate immune factors such
as complement, lysozyme and acute phase proteins such as serum
amyloid protein a (SAA) play a role. Thus, SAA transcripts are
highly increased in Y. ruckeri infected rainbow trout [19]. SAA can
bind to the outer membrane protein A (OmpA), a conserved
protein among the Gram-negative bacteria belonging to Entero-
bacteriaceae.
Although immersion vaccination with ERM bacterin is
effective, it cannot prevent the appearance of outbreaks under
severe stress conditions, due to exposure to a large number of
bacteria disseminated by carriers and diseased fish [20]. Hence,
there seems to be a discrepancy between laboratory and field tests.
In particular, this regards to the duration of protection that appear
to vary under farming conditions [16]. Therefore, it has been
recommended that rainbow trout should be given an oral booster
two to three months post immersion vaccination under field
conditions in order to increase the length of immunity to cover the
growth period in freshwater [21]. In the present experiment a
commercial oral booster vaccine (AquaVacTM ERM Oral vet) was
fed to one group of fish 16 weeks post immersion vaccination with
AquaVacTM ERM as recommended by the manufacturer. The
orally booster vaccinated fish showed 0% mortality during
challenge with Y. ruckeri (Fig. 2 B). However, we were not able
to show improved protection compared to fish that only received
the AquaVacTM ERM immersion vaccine since they also showed
0% mortality following Y. ruckeri challenge (Fig. 2B). Further, the
oral booster vaccination did not change the bactericidal effect of
plasma and decreased the Y. ruckeri specific IgM titers relative to
the group of fish that only received the AquaVacTM ERM
immersion vaccine.
Recently it has been shown that Y. ruckeri has the capacity of
surviving intracellularly in rainbow trout [22] which fits well
with our finding of Y. ruckeri O1 biotype 1 in the head kidney of
apparently healthy rainbow trout 6 month post i.p. infection
(unpublished). Up-regulation of CD-8a transcript is previously
described in ERM immersion vaccinated and protected
rainbow trout fry, which indicates that activity of cytotoxic T-
cells could play a role in the cellular adaptive protection
mechanisms against intracellular Y. ruckeri stages during
infection [15]. The present study has shown that antibody
titers and the bactericidal effect of plasma increase in ERM
immersion vaccinated rainbow trout. Moreover, this is
associated with a reduced bacteremia and increased protective
immunity against Y. ruckeri infection. Although other humoral
and cellular elements may play a role in immersion vaccine
induce protection of rainbow trout against ERM, the present
study has indicated that specific plasma antibodies may take
part in immunity towards Y. ruckeri.
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Figure 5. Bactericidal effect of rainbow trout plasma. The
present experiment shows that plasma from sham vaccinated rainbow
trout contains factors that are able to kill a significant amount of Y.
ruckeri (A, p,0.01 and B) p,0.05. Further it is shown that plasma
obtained from immersion vaccinated trout kill a significant higher
amount of Y. ruckeri than plasma from sham-vaccinated trout. Bars
represent mean values + SD values. * Depicts statistical significance
between groups (*P,0.05; **P,0.01; ***P,0.001).
doi:10.1371/journal.pone.0018832.g005
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